ニュージーランド - 英語 - Medsafe (Medicines Safety Authority)

medsurge pharma limited - alfentanil hydrochloride 0.544 mg/ml equivalent to alfentanil 0.5mg/ml - solution for injection - 1 mg/2ml - active: alfentanil hydrochloride 0.544 mg/ml equivalent to alfentanil 0.5mg/ml excipient: sodium chloride sodium hydroxide water for injection - alfentanil injection is indicated in adults and children aged above one year for use as: · an opioid analgesic in general or regional anaesthesia for both short (bolus injections) and long (bolus, supplemented by increments or by continuous infusion) surgical procedures. · an anaesthetic induction agent. due to its rapid and short-lasting action, alfentanil injection is particularly suited as an opioid analgesic for short procedures and outpatient surgery. it is also useful as an analgesic supplement for procedures of medium and long duration, since periods of very painful stimuli can easily be overcome by small increments of alfentanil injection or by adapting its infusion rate.

ニュージーランド - 英語 - Medsafe (Medicines Safety Authority)

medsurge pharma limited - alfentanil hydrochloride 0.544 mg/ml equivalent to alfentanil 0.5mg/ml - solution for injection - 5 mg/10ml - active: alfentanil hydrochloride 0.544 mg/ml equivalent to alfentanil 0.5mg/ml excipient: sodium chloride sodium hydroxide water for injection - alfentanil injection is indicated in adults and children aged above one year for use as: · an opioid analgesic in general or regional anaesthesia for both short (bolus injections) and long (bolus, supplemented by increments or by continuous infusion) surgical procedures. · an anaesthetic induction agent. due to its rapid and short-lasting action, alfentanil injection is particularly suited as an opioid analgesic for short procedures and outpatient surgery. it is also useful as an analgesic supplement for procedures of medium and long duration, since periods of very painful stimuli can easily be overcome by small increments of alfentanil injection or by adapting its infusion rate.

アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

hospira uk limited - remifentanil hydrochloride - pdr/conc/soln/inj/inf - 1 milligram - opioid anesthetics

アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

hospira uk limited - remifentanil hydrochloride - pdr/conc/soln/inj/inf - 2 milligram - opioid anesthetics

アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

hospira uk limited - remifentanil hydrochloride - pdr/conc/soln/inj/inf - 5 milligram - opioid anesthetics

ニュージーランド - 英語 - Medsafe (Medicines Safety Authority)

max health limited - alfentanil hydrochloride monohydrate 0.5438 mg/ml equivalent to alfentanil 0.5 mg/ml;   - solution for injection - 0.5 mg/ml - active: alfentanil hydrochloride monohydrate 0.5438 mg/ml equivalent to alfentanil 0.5 mg/ml   excipient: hydrochloric acid nitrogen sodium chloride water for injection - an anaesthetic induction agent.

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

mylan institutional llc - remifentanil hydrochloride (unii: 5v444h5wic) (remifentanil - unii:p10582jyyk) - remifentanil 1 mg in 1 ml - ultiva is indicated for intravenous (iv) administration: ultiva is contraindicated: prolonged use of opioid analgesics during pregnancy may cause neonatal opioid withdrawal syndrome. available data with remifentanil hydrochloride in pregnant women are insufficient to inform a drug-associated risk for major birth defects and miscarriage. in animal reproduction studies, reduced fetal rat body weight and pup weights were reported at 2.2 times a human intravenous infusion of an induction dose of 1 mcg/kg with a maintenance dose of 2 mcg/kg/min for a surgical procedure lasting 3 hours. there were no malformations noted when remifentanil was administered via bolus injection to pregnant rats or rabbits during organogenesis at doses approximately 5 times and approximately equal, respectively, to a human intravenous infusion of an induction dose of 1 mcg/kg with a maintenance dose of 2 mcg/kg/min for a surgical procedure lasting 3 hours [see data ]. the estimated background risk of major birth defects and miscarriage

イギリス - 英語 - MHRA (Medicines & Healthcare Products Regulatory Agency)

hameln pharma ltd - alfentanil hydrochloride - solution for injection - 500microgram/1ml

イギリス - 英語 - MHRA (Medicines & Healthcare Products Regulatory Agency)

hameln pharma ltd - alfentanil hydrochloride - solution for injection - 5mg/1ml

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

medsurge pharma pty ltd - alfentanil hydrochloride, quantity: 5.44 mg (equivalent: alfentanil, qty 5 mg) - injection, solution - excipient ingredients: water for injections; sodium hydroxide; sodium chloride - alfentanil injection is indicated for intravenous use by specialist anaesthetists and their trainees as:,? an analgesic supplement given by incremental intravenous boluses or continuous infusion; and,? an anaesthetic induction agent where in patients undergoing in-patient surgery, when endotracheal intubation and controlled ventilation are to be used.,because of its rapid onset and short duration of action, intravenous alfentanil (as hydrochloride) is particularly suited as a narcotic analgesic for short procedures and outpatients, provided that the patients are maintained under appropriate post-operative surveillance. however, intravenous alfentanil (as hydrochloride) is also useful as an analgesic supplement for procedures of medium to long duration, since periods of very painful stimuli can be easily overcome by administration of small increments of alfentanil (as hydrochloride) or by adapting the infusion rate.